Literature DB >> 23812090

Swimming exercise training-induced left ventricular hypertrophy involves microRNAs and synergistic regulation of the PI3K/AKT/mTOR signaling pathway.

Zhichao Ma1, Jie Qi, Shuai Meng, Baoju Wen, Jun Zhang.   

Abstract

PURPOSE: Swimming exercise leads to a nonpathological, physiological left ventricular hypertrophy. However, the potential molecular mechanisms are unknown. We investigated the role of microRNAs (miRNA) regulating the cardiac signal cascades were studied in exercised rats.
METHODS: Female Wistar rats were assigned into two groups: (1) sedentary control (SC), (2) swimming exercise (SE). The rats in the SE group completed a 1-h swimming exercise, 5 times/week/8-week with 5 % body overload. miRNA, phosphoinositide-3-kinase catalytic alpha polypeptide (PIK3α), phosphatase and tensin homolog (PTEN) and tuberous sclerosis complex 2 (TSC2) gene expression analysis were performed by real-time PCR in heart muscle. Moreover, we assessed cardiac protein expression of ERK1/2, PI3K/AKT/mTOR, PTEN and TSC2.
RESULTS: Cardiac phospho(ser473)-AKT and phospho(Ser2448)-mTOR were, respectively, increased by 46 and 38 % in the SE group when compared with SC group. miRNAs-21, 144, and 145 were, respectively, up-regulated in the SE group (152 %, 128, and 101 % relative increases), but miRNA-124 was decreased by 38 %. In SE group, PIK3α (targeted by miRNA-124) gene expression increased by 213 %, and Pten (targeted by miRNAs-21 and 144), and TSC2 (targeted by miRNA-145) were, respectively, decreased by 51 and 55 %. In addition, the swimming exercise increased protein levels of PIK3α (36 %) and phospho(Thr1462)-TSC2 (48 %), while it decreased PTEN (37 %) and TSC2 (22 %), which induced activation of PI3K/AKT/mTOR signaling pathway.
CONCLUSION: These findings are consistent with a model in which exercise may induce left ventricular hypertrophy, at least in part, changing the expression of specific miRNAs targeting the PIK3/AKT/mTOR signaling pathway and its negative regulators.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23812090     DOI: 10.1007/s00421-013-2685-9

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  81 in total

Review 1.  MicroRNAs in vertebrate development.

Authors:  Brian D Harfe
Journal:  Curr Opin Genet Dev       Date:  2005-08       Impact factor: 5.578

Review 2.  MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets.

Authors:  Eva van Rooij; Eric N Olson
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

3.  Rapamycin attenuates load-induced cardiac hypertrophy in mice.

Authors:  Tetsuo Shioi; Julie R McMullen; Oleg Tarnavski; Kimber Converso; Megan C Sherwood; Warren J Manning; Seigo Izumo
Journal:  Circulation       Date:  2003-03-17       Impact factor: 29.690

Review 4.  Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.

Authors:  Julie R McMullen; Garry L Jennings
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-04       Impact factor: 2.557

5.  Domain swapping used to investigate the mechanism of protein kinase B regulation by 3-phosphoinositide-dependent protein kinase 1 and Ser473 kinase.

Authors:  M Andjelković; S M Maira; P Cron; P J Parker; B A Hemmings
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

6.  Effects of fasting and refeeding on expression of atrogin-1 and Akt/FOXO signaling pathway in skeletal muscle of chicks.

Authors:  Kazuki Nakashima; Yoko Yakabe; Makoto Yamazaki; Hiroyuki Abe
Journal:  Biosci Biotechnol Biochem       Date:  2006-11-07       Impact factor: 2.043

7.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

Authors:  Mariko Tatsuguchi; Hee Young Seok; Thomas E Callis; J Michael Thomson; Jian-Fu Chen; Martin Newman; Mauricio Rojas; Scott M Hammond; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2007-04-14       Impact factor: 5.000

8.  Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo.

Authors:  Nicole H Purcell; Benjamin J Wilkins; Allen York; Marc K Saba-El-Leil; Sylvain Meloche; Jeffrey Robbins; Jeffery D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

9.  Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.

Authors:  Julie R McMullen; Megan C Sherwood; Oleg Tarnavski; Li Zhang; Adam L Dorfman; Tetsuo Shioi; Seigo Izumo
Journal:  Circulation       Date:  2004-06-07       Impact factor: 29.690

Review 10.  The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.

Authors:  Jingxiang Huang; Brendan D Manning
Journal:  Biochem J       Date:  2008-06-01       Impact factor: 3.857

View more
  39 in total

Review 1.  What do we know about the cardiac benefits of exercise?

Authors:  Xin Wei; Xiaojun Liu; Anthony Rosenzweig
Journal:  Trends Cardiovasc Med       Date:  2014-12-31       Impact factor: 6.677

2.  Autophagy inhibitor 3-methyladenine alleviates overload-exercise-induced cardiac injury in rats.

Authors:  Hua Liu; Hui Lei; Yue Shi; Jin-Ju Wang; Ning Chen; Zhang-Hua Li; Yan-Fang Chen; Qi-Fa Ye; Yi Yang
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

Review 3.  Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs.

Authors:  Tiago Fernandes; Valério G Baraúna; Carlos E Negrão; M Ian Phillips; Edilamar M Oliveira
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-12       Impact factor: 4.733

Review 4.  The Role of MicroRNAs in the Cardiac Response to Exercise.

Authors:  Xiaojun Liu; Colin Platt; Anthony Rosenzweig
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

Review 5.  Noncoding RNAs in Cardiac Hypertrophy.

Authors:  Yongqin Li; Yajun Liang; Yujiao Zhu; Yuhui Zhang; Yihua Bei
Journal:  J Cardiovasc Transl Res       Date:  2018-08-31       Impact factor: 4.132

Review 6.  Differential expression of microRNAs in ischemic heart disease.

Authors:  Minwoo A Song; Alexandra N Paradis; Maresha S Gay; John Shin; Lubo Zhang
Journal:  Drug Discov Today       Date:  2014-10-23       Impact factor: 7.851

Review 7.  Using exercise to measure and modify cardiac function.

Authors:  Colin Platt; Nicholas Houstis; Anthony Rosenzweig
Journal:  Cell Metab       Date:  2015-02-03       Impact factor: 27.287

Review 8.  Exercise: putting action into our epigenome.

Authors:  Joshua Denham; Francine Z Marques; Brendan J O'Brien; Fadi J Charchar
Journal:  Sports Med       Date:  2014-02       Impact factor: 11.136

9.  Overexpression of miR-223 Tips the Balance of Pro- and Anti-hypertrophic Signaling Cascades toward Physiologic Cardiac Hypertrophy.

Authors:  Liwang Yang; Yutian Li; Xiaohong Wang; Xingjiang Mu; Dongze Qin; Wei Huang; Saeed Alshahrani; Michelle Nieman; Jiangtong Peng; Kobina Essandoh; Tianqing Peng; Yigang Wang; John Lorenz; Manoocher Soleimani; Zhi-Qing Zhao; Guo-Chang Fan
Journal:  J Biol Chem       Date:  2016-05-20       Impact factor: 5.157

10.  Prognostic significance of microRNA expression in completely resected lung adenocarcinoma and the associated response to erlotinib.

Authors:  Guanzhong Yan; Ruyong Yao; Dongfang Tang; Tong Qiu; Yi Shen; Wenjie Jiao; Nan Ge; Yunpeng Xuan; Yongjie Wang
Journal:  Med Oncol       Date:  2014-09-06       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.